Oslo, Norway, 30 April 2024: Photocure ASA (OSE: PHO), calls for the annual
general meeting of Photocure ASA to be held on 23 May 2024 at 17:00 hours
(CEST), virtual through the general meeting portal administered by Euronext
Securities Oslo (the "Euronext Securities Portal").
The general meeting will be webcasted live and a link will be available on the
company's website in due time in advance of the general meeting. It will not be
possible to attend in person. Shareholders may also vote in advance or submit a
proxy with voting instructions.
The notice convening the general meeting, including the agenda and the board's
proposals to the matters to be dealt with, is enclosed with this notification
and will be sent to all shareholders with known addresses.
Relevant documents referred to in the notice are made available on
www.photocure.com.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000
Email: ed@photocure.com
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, which makes
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com or www.cysview.com
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.